Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Revolution Medicines is seeking a Director, Medical Affairs for BeLux to lead local medical strategy and execution for the oncology portfolio. You will align global strategy with BeLux needs, build strong KOL relationships, and drive medical launch readiness in a rapidly evolving environment.
With 10+ years in Medical Affairs and advanced oncology expertise, you will collaborate with regional and global teams, ensure compliant scientific communication, and help shape lifecycle management and
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
Reporting to the Country Manager BeLux, the Director, Medical Affairs, BeLux is the medical leader responsible for defining and executing the local medical strategy RevMed portfolio and launches. This role serves as the medical voice within the BeLux Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs.
This leader will ensure that BeLux medical considerations are embedded in the regional medical strategy and plans and will partner with the Country Manager and crossfunctional teams, as well as the Sr Dir Medical Affairs Midsized Markets and VP Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the BeLux medical team and work closely with the Midsized Markets crossfuncitonal and cross-country teams, Global and Regional Medical Affairs teams across Med Affairs functions.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to careers@revmed.com so we can share these impersonations with our IT team for tracking and awareness.